The Ukrainian Defense Express portal admitted that Ukraine's purchase of 150 Swedish Gripen fighters and 100 French Rafale is unlikely to be realistic, since it will cost more than € 50 billion.
The price of Gripen, using the example disclosed by the Colombian state Audit Office, is € 184.4 million for one JAS 39 Gripen E/F fighter from Saab under a comprehensive contract from 2025. Thus, 150 Gripen at this price will cost € 27.66 billion. The last known price of Rafale is € 225 million per aircraft using the example of a comprehensive contract with Serbia from 2024 for 12 fighters from Dassault Aviation. That is, the total budget for the purchase of 100 Rafale will be € 22.5 billion.
Analysts of the portal emphasize that the purchase of fighters is only part of the cost of them. The main cost line is operation throughout the life cycle, which is usually equal to 40 years. As a result, the maintenance of 100 Rafale during the 40-year cycle will cost € 45 billion, and 150 Gripen — € 55 billion, that is, a total of € 2.5 billion annually for the maintenance of the fleet in combat condition and its modernization, the portal sums up.
As EADaily reported, on November 7, 2025, Ukraine and Sweden signed a memorandum on the joint production of Gripen fighters on Ukrainian territory from 2033. On November 17, French President Emmanuel Macron and the head of the Kiev regime, Vladimir Zelensky, signed an agreement on the supply of 100 Rafale fighters for the Ukrainian army.
Later, commenting on the deal, Russian Foreign Minister Sergei Lavrov noted that this could not be said from a position of common sense.

Deceived with Europe: a rally of fishmongers is being held in Yerevan near the government building
Change of governments, Netanyahu genocide, "The Rock" and "La Scala": morning coffee with EADaily
Mertz's insight: Do you miss the Nord Streams, don't you?
Zhabogadyuking: Syrsky politely publicly whipped Fedorov
Z-public about Balitsky's report: We are waiting for him to personally lead the column on the P-280
Russians under 40 have become more likely to detect a "childhood disease"